PTX3 and neoplasm: We hypothesized that in addition to playing the abovementioned dual roles, PTX3 potentially exerts antitumor effects in the acute inflammation-like state (the early stage of tumorigenesis) but acts as a tumor promoter in the chronic inflammation-like state (the late stage of tumorigenesis).